Description
Evonik Industries: Initiation of Coverage- Will Methionine Market Tightness Trigger a Massive Upside Surprise?
Evonik Industries AG, a global leader in specialty chemicals, reported a positive performance in the first quarter of 2025. The company achieved a significant year-over-year increase in EBITDA and free cash flow, surpassing the prior year’s figures by over 50%. Despite a challenging macroeconomic environment, Evonik maintained its full-year guidance, buoyed by strong performance in its Specialty Additives and Nutrition & Care segments.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
